Home/Filings/4/0001209191-18-044920
4//SEC Filing

Doherty Michael J 4

Accession 0001209191-18-044920

CIK 0001488613other

Filed

Aug 1, 8:00 PM ET

Accepted

Aug 2, 4:04 PM ET

Size

7.9 KB

Accession

0001209191-18-044920

Insider Transaction Report

Form 4
Period: 2018-07-31
Doherty Michael J
Head of Product Development
Transactions
  • Disposition from Tender

    Common Stock

    2018-07-31$137.00/sh15,955$2,185,83565,332 total
  • Other

    Common Stock

    2018-07-31$137.00/sh65,332$8,950,4840 total
Footnotes (3)
  • [F1]Foundation Medicine, Inc., a Delaware corporation (the "Company") entered into an Agreement and Plan of Merger, dated as of June 18, 2018, as amended (the "Merger Agreement"), with Roche Holdings, Inc., a Delaware corporation ("Parent" or "Roche"), and 062018 Merger Subsidiary, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"). Pursuant to the Merger Agreement, Parent caused Merger Sub to conduct a tender offer (the "Tender Offer") for all of the issued and outstanding shares of common stock, par value $0.0001 per share, of the Company, at a price of $137 per share. On July 31, 2018, Merger Sub irrevocably accepted for payment all shares that were validly tendered and not withdrawn. On July 31, 2018, following consummation of the Tender Offer, Merger Sub merged with and into the Company.
  • [F2]The amount reported represents the number of shares sold by the reporting person in connection with the Tender Offer by Roche.
  • [F3]The amount reported represents the number of unvested restricted stock units cancelled in connection with the Tender Offer by Roche and converted into the right to receive an amount in cash equal to the product of (1) the offer price of $137 per share multiplied by (2) the number of shares represented by such unvested restricted stock units, without interest and less any required withholding taxes. Payments are subject to the original vesting schedule and vesting conditions applicable to the underlying unvested restricted stock units.

Issuer

Foundation Medicine, Inc.

CIK 0001488613

Entity typeother

Related Parties

1
  • filerCIK 0001710939

Filing Metadata

Form type
4
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 4:04 PM ET
Size
7.9 KB